Genital warts are one of the most common sexually transmitted conditions. About 1% of sexually active adults in the United States have visible genital warts at any given time, and roughly 6.3% of women and 2.8% of men report having had them at some point in their lives. Those numbers only capture the visible cases. The underlying virus, HPV, is far more widespread.
How Many People Carry the Virus
Genital warts are caused by certain strains of human papillomavirus, most often types 6 and 11. But HPV infection itself is extremely common. According to the World Health Organization, nearly 1 in 3 men over age 15 worldwide carry at least one genital HPV type. Among women, infection rates are similarly high, particularly in younger age groups.
Most people who contract HPV never develop visible warts. While about 1% of sexually active adults have warts you can see or feel, at least 15% have a subclinical infection, meaning the virus is present in their tissue but produces no visible symptoms. In other words, for every person with noticeable warts, roughly 15 more carry the virus without knowing it. This is a major reason HPV spreads so easily.
Peak Age for Diagnosis
HPV prevalence climbs steeply in the late teens and early twenties, reaching its highest levels between ages 25 and 29. After that, rates either stabilize or drop slightly. This pattern reflects the reality that HPV is most commonly picked up in the first few years of sexual activity. Since genital warts typically appear weeks to months after exposure, diagnoses tend to cluster in this same age window.
Differences Between Men and Women
Women report a history of genital warts more than twice as often as men (6.3% versus 2.8%). Part of this gap is likely due to detection: women are more frequently screened during routine gynecological exams, and warts on the cervix or vaginal walls may be identified during those visits. In men, warts on the shaft of the penis are usually self-detected, but those in less visible areas, like the urethra or around the anus, can go unnoticed for longer.
The global HPV infection rate in men, roughly 31%, suggests that many male carriers simply never develop symptoms or never realize they have them. This doesn’t mean men are less affected. It means the gap between infection and diagnosis is wider.
What Happens After Treatment
Genital warts are treatable, but recurrence is common. The estimated recurrence rate sits around 30 to 35%, with at least 20% of cases reappearing within the first 12 weeks after initial treatment. This happens because treatments remove visible warts but don’t eliminate the virus from surrounding skin. Over time, the immune system typically suppresses HPV on its own, but that process can take months to years, and new warts can appear during that window.
If you’ve been treated for genital warts and they come back, that’s a normal part of the infection’s course, not a sign that treatment failed. Most people eventually clear the virus, but the timeline varies widely from person to person.
How Vaccination Is Changing the Numbers
The HPV vaccine, which protects against the two strains responsible for about 90% of genital warts, has dramatically reduced case rates in countries with high vaccination coverage. A large meta-analysis covering 60 million vaccinated people across 14 high-income countries found that even in programs that initially vaccinated only girls, the benefits extended to unvaccinated males. Within eight years of those programs starting, genital wart diagnoses dropped by 48% among boys aged 15 to 19, by 32% among men aged 20 to 24, and by 31% among women aged 25 to 29.
These declines reflect herd immunity: when enough people are vaccinated, the virus circulates less, protecting even those who haven’t been vaccinated. In countries like Australia, where vaccination rates are especially high, genital warts have become rare in younger age groups. The vaccine is most effective when given before any HPV exposure, which is why it’s routinely recommended in early adolescence, but it provides benefit up through age 26 for most people and up to age 45 in some cases.
Why the True Number Is Hard to Pin Down
Genital warts aren’t a reportable condition in most countries, meaning doctors aren’t required to notify public health authorities when they diagnose a case. Prevalence estimates come from surveys, insurance claims, and clinic records, all of which miss people who never seek care. Many people with small or painless warts may not realize what they are, or may feel too embarrassed to bring them up with a provider. The 1% visible prevalence figure is almost certainly an undercount of the true burden at any given moment, and the lifetime risk figures (6.3% for women, 2.8% for men) likely underestimate as well, since they rely on self-reported history.
What’s clear from the data is that genital warts are common enough that having them is not unusual or a reflection of anything other than normal sexual activity. The vast majority of sexually active people encounter HPV at some point, and a meaningful fraction of them will develop visible warts, even if most won’t.